✦ LIBER ✦

Different impact of IL28B polymorphisms on response to peginterferon-α plus ribavirin in HIV-positive patients infected with HCV subtypes 1a or 1b

✍ Scribed by Eugenia Vispo; Norma I. Rallon; Pablo Labarga; Pablo Barreiro; Jose Miguel Benito; Vincent Soriano

Book ID: 116632364
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 251 KB
Volume: 55
Category: Article
ISSN: 1386-6532
DOI: 10.1016/j.jcv.2012.05.012

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Predictive value of early viral dynamics

Predictive value of early viral dynamics during peginterferon and ribavirin combination therapy based on genetic polymorphisms near the IL28B gene in patients infected with HCV genotype 1b

✍ Hidenori Toyoda; Takashi Kumada; Toshifumi Tada; Kazuhiko Hayashi; Takashi Honda 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 242 KB 👁 1 views

## Abstract A study was carried out to determine whether early viral dynamics retain prediction of the outcome of peginterferon (PEG‐IFN) and ribavirin combination therapy based on different genetic polymorphisms near the __IL28B__ gene, the strongest baseline predictor of response to this therapy.

Impact of IL28B on treatment outcome in

Impact of IL28B on treatment outcome in hepatitis C virus G1/4 patients receiving response-guided therapy with peginterferon alpha-2a (40KD)/ribavirin

✍ Thomas-Matthias Scherzer; Albert Friedrich Stättermayer; Michael Strasser; Herma 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 502 KB

The IL28B genotype is the most important pretreatment predictor of treatment outcome in patients with chronic hepatitis C. The impact of the rs12979860 genotype on relapse was retrospectively evaluated in genotype 1/4 patients who received response-guided therapy with peginterferon alpha-2a 180 μg/w